Pharmacogenetics, cost of genotyping, and guidelines for individualizing therapy with mercaptopurine in pediatric acute lymphoblastic leukemia

Pediatr Blood Cancer. 2011 Dec 15;57(7):1247. doi: 10.1002/pbc.23249. Epub 2011 Jul 27.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage*
  • Clinical Enzyme Tests / economics*
  • Genetic Testing / economics*
  • Humans
  • Mercaptopurine / administration & dosage*
  • Methyltransferases / deficiency*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / enzymology*

Substances

  • Antimetabolites, Antineoplastic
  • Mercaptopurine
  • Methyltransferases